HIGHLIGHTS
- who: Report and collaborators from the Diagnostic workup Laboratory studies revealed endogenous hyperinsulinism-inappropriately high insulin levels during a hypoglycemic episode and insulin to, peptide ratio inferior to , (Table, )Surreptitious administration of sulfonylureas was excluded with the available sulfonylurea assay that tests for glibenclamide, tolbutamide, and chlorpropamide. Anti-insulin and anti-insulin receptor antibodies were also negative. Insulin-like growth factor , (IGF-1) dosing was within the normal range. Free fatty acids, beta-hydroxybutyrate, and acetoacetate were inappropriately low for the glucose plasma concentration, which was consistent with hyperinsulinism. have published the Article: Review began 08/13 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.